The multiple PDZ domain protein Mpdz/MUPP1 regulates opioid tolerance and opioid-induced hyperalgesia

Robin Donaldson, Yuan Sun, De Yong Liang, Ming Zheng, Peyman Sahbaie, David L. Dill, Gary Peltz, Kari Buck, J. David Clark

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Opioids are a mainstay for the treatment of chronic pain. Unfortunately, therapy-limiting maladaptations such as loss of treatment effect (tolerance), and paradoxical opioid-induced hyperalgesia (OIH) can occur. The objective of this study was to identify genes responsible for opioid tolerance and OIH. Results: These studies used a well-established model of ascending morphine administration to induce tolerance, OIH and other opioid maladaptations in 23 strains of inbred mice. Genome-wide computational genetic mapping was then applied to the data in combination with a false discovery rate filter. Transgenic mice, gene expression experiments and immunoprecipitation assays were used to confirm the functional roles of the most strongly linked gene. The behavioral data processed using computational genetic mapping and false discovery rate filtering provided several strongly linked biologically plausible gene associations. The strongest of these was the highly polymorphic Mpdz gene coding for the post-synaptic scaffolding protein Mpdz/MUPP1. Heterozygous Mpdz +/- mice displayed reduced opioid tolerance and OIH. Mpdz gene expression and Mpdz/MUPP1 protein levels were lower in the spinal cords of low-adapting 129S1/Svlm mice than in high-adapting C57BL/6 mice. Morphine did not alter Mpdz expression levels. In addition, association of Mpdz/MUPP1 with its known binding partner CaMKII did not differ between these high- and low-adapting strains. Conclusions: The degrees of maladaptive changes in response to repeated administration of morphine vary greatly across inbred strains of mice. Variants of the multiple PDZ domain gene Mpdz may contribute to the observed inter-strain variability in tolerance and OIH by virtue of changes in the level of their expression.

Original languageEnglish (US)
Article number313
JournalBMC Genomics
Volume17
Issue number1
DOIs
StatePublished - Apr 29 2016

Fingerprint

PDZ Domains
Hyperalgesia
Opioid Analgesics
Proteins
Morphine
Inbred Strains Mice
Genes
Gene Expression
Calcium-Calmodulin-Dependent Protein Kinase Type 2
Inbred C57BL Mouse
Immunoprecipitation
Chronic Pain
Transgenic Mice
Spinal Cord
Therapeutics
Genome

Keywords

  • Drug tolerance
  • Gene mapping
  • Opioid analgesics
  • Synaptic plasticity

ASJC Scopus subject areas

  • Biotechnology
  • Genetics

Cite this

Donaldson, R., Sun, Y., Liang, D. Y., Zheng, M., Sahbaie, P., Dill, D. L., ... Clark, J. D. (2016). The multiple PDZ domain protein Mpdz/MUPP1 regulates opioid tolerance and opioid-induced hyperalgesia. BMC Genomics, 17(1), [313]. https://doi.org/10.1186/s12864-016-2634-1

The multiple PDZ domain protein Mpdz/MUPP1 regulates opioid tolerance and opioid-induced hyperalgesia. / Donaldson, Robin; Sun, Yuan; Liang, De Yong; Zheng, Ming; Sahbaie, Peyman; Dill, David L.; Peltz, Gary; Buck, Kari; Clark, J. David.

In: BMC Genomics, Vol. 17, No. 1, 313, 29.04.2016.

Research output: Contribution to journalArticle

Donaldson, R, Sun, Y, Liang, DY, Zheng, M, Sahbaie, P, Dill, DL, Peltz, G, Buck, K & Clark, JD 2016, 'The multiple PDZ domain protein Mpdz/MUPP1 regulates opioid tolerance and opioid-induced hyperalgesia', BMC Genomics, vol. 17, no. 1, 313. https://doi.org/10.1186/s12864-016-2634-1
Donaldson, Robin ; Sun, Yuan ; Liang, De Yong ; Zheng, Ming ; Sahbaie, Peyman ; Dill, David L. ; Peltz, Gary ; Buck, Kari ; Clark, J. David. / The multiple PDZ domain protein Mpdz/MUPP1 regulates opioid tolerance and opioid-induced hyperalgesia. In: BMC Genomics. 2016 ; Vol. 17, No. 1.
@article{4ef556c9f36340ea98a34a1f0b59c2ed,
title = "The multiple PDZ domain protein Mpdz/MUPP1 regulates opioid tolerance and opioid-induced hyperalgesia",
abstract = "Background: Opioids are a mainstay for the treatment of chronic pain. Unfortunately, therapy-limiting maladaptations such as loss of treatment effect (tolerance), and paradoxical opioid-induced hyperalgesia (OIH) can occur. The objective of this study was to identify genes responsible for opioid tolerance and OIH. Results: These studies used a well-established model of ascending morphine administration to induce tolerance, OIH and other opioid maladaptations in 23 strains of inbred mice. Genome-wide computational genetic mapping was then applied to the data in combination with a false discovery rate filter. Transgenic mice, gene expression experiments and immunoprecipitation assays were used to confirm the functional roles of the most strongly linked gene. The behavioral data processed using computational genetic mapping and false discovery rate filtering provided several strongly linked biologically plausible gene associations. The strongest of these was the highly polymorphic Mpdz gene coding for the post-synaptic scaffolding protein Mpdz/MUPP1. Heterozygous Mpdz +/- mice displayed reduced opioid tolerance and OIH. Mpdz gene expression and Mpdz/MUPP1 protein levels were lower in the spinal cords of low-adapting 129S1/Svlm mice than in high-adapting C57BL/6 mice. Morphine did not alter Mpdz expression levels. In addition, association of Mpdz/MUPP1 with its known binding partner CaMKII did not differ between these high- and low-adapting strains. Conclusions: The degrees of maladaptive changes in response to repeated administration of morphine vary greatly across inbred strains of mice. Variants of the multiple PDZ domain gene Mpdz may contribute to the observed inter-strain variability in tolerance and OIH by virtue of changes in the level of their expression.",
keywords = "Drug tolerance, Gene mapping, Opioid analgesics, Synaptic plasticity",
author = "Robin Donaldson and Yuan Sun and Liang, {De Yong} and Ming Zheng and Peyman Sahbaie and Dill, {David L.} and Gary Peltz and Kari Buck and Clark, {J. David}",
year = "2016",
month = "4",
day = "29",
doi = "10.1186/s12864-016-2634-1",
language = "English (US)",
volume = "17",
journal = "BMC Genomics",
issn = "1471-2164",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The multiple PDZ domain protein Mpdz/MUPP1 regulates opioid tolerance and opioid-induced hyperalgesia

AU - Donaldson, Robin

AU - Sun, Yuan

AU - Liang, De Yong

AU - Zheng, Ming

AU - Sahbaie, Peyman

AU - Dill, David L.

AU - Peltz, Gary

AU - Buck, Kari

AU - Clark, J. David

PY - 2016/4/29

Y1 - 2016/4/29

N2 - Background: Opioids are a mainstay for the treatment of chronic pain. Unfortunately, therapy-limiting maladaptations such as loss of treatment effect (tolerance), and paradoxical opioid-induced hyperalgesia (OIH) can occur. The objective of this study was to identify genes responsible for opioid tolerance and OIH. Results: These studies used a well-established model of ascending morphine administration to induce tolerance, OIH and other opioid maladaptations in 23 strains of inbred mice. Genome-wide computational genetic mapping was then applied to the data in combination with a false discovery rate filter. Transgenic mice, gene expression experiments and immunoprecipitation assays were used to confirm the functional roles of the most strongly linked gene. The behavioral data processed using computational genetic mapping and false discovery rate filtering provided several strongly linked biologically plausible gene associations. The strongest of these was the highly polymorphic Mpdz gene coding for the post-synaptic scaffolding protein Mpdz/MUPP1. Heterozygous Mpdz +/- mice displayed reduced opioid tolerance and OIH. Mpdz gene expression and Mpdz/MUPP1 protein levels were lower in the spinal cords of low-adapting 129S1/Svlm mice than in high-adapting C57BL/6 mice. Morphine did not alter Mpdz expression levels. In addition, association of Mpdz/MUPP1 with its known binding partner CaMKII did not differ between these high- and low-adapting strains. Conclusions: The degrees of maladaptive changes in response to repeated administration of morphine vary greatly across inbred strains of mice. Variants of the multiple PDZ domain gene Mpdz may contribute to the observed inter-strain variability in tolerance and OIH by virtue of changes in the level of their expression.

AB - Background: Opioids are a mainstay for the treatment of chronic pain. Unfortunately, therapy-limiting maladaptations such as loss of treatment effect (tolerance), and paradoxical opioid-induced hyperalgesia (OIH) can occur. The objective of this study was to identify genes responsible for opioid tolerance and OIH. Results: These studies used a well-established model of ascending morphine administration to induce tolerance, OIH and other opioid maladaptations in 23 strains of inbred mice. Genome-wide computational genetic mapping was then applied to the data in combination with a false discovery rate filter. Transgenic mice, gene expression experiments and immunoprecipitation assays were used to confirm the functional roles of the most strongly linked gene. The behavioral data processed using computational genetic mapping and false discovery rate filtering provided several strongly linked biologically plausible gene associations. The strongest of these was the highly polymorphic Mpdz gene coding for the post-synaptic scaffolding protein Mpdz/MUPP1. Heterozygous Mpdz +/- mice displayed reduced opioid tolerance and OIH. Mpdz gene expression and Mpdz/MUPP1 protein levels were lower in the spinal cords of low-adapting 129S1/Svlm mice than in high-adapting C57BL/6 mice. Morphine did not alter Mpdz expression levels. In addition, association of Mpdz/MUPP1 with its known binding partner CaMKII did not differ between these high- and low-adapting strains. Conclusions: The degrees of maladaptive changes in response to repeated administration of morphine vary greatly across inbred strains of mice. Variants of the multiple PDZ domain gene Mpdz may contribute to the observed inter-strain variability in tolerance and OIH by virtue of changes in the level of their expression.

KW - Drug tolerance

KW - Gene mapping

KW - Opioid analgesics

KW - Synaptic plasticity

UR - http://www.scopus.com/inward/record.url?scp=84966330270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966330270&partnerID=8YFLogxK

U2 - 10.1186/s12864-016-2634-1

DO - 10.1186/s12864-016-2634-1

M3 - Article

C2 - 27129385

AN - SCOPUS:84966330270

VL - 17

JO - BMC Genomics

JF - BMC Genomics

SN - 1471-2164

IS - 1

M1 - 313

ER -